Hypomethylation of PRAME promoter is associated with poor prognosis in myelodysplastic syndrome

British Journal of Haematology

Volumn 154, Issue 1, 2011, Pages 153-155

  Qian, Jun ^a   Zhu, Zhao hui ^a   Lin, Jiang ^b   ming Yao, Dong Ming ^a   Li, Yun ^a   Yang, Jing ^a   Wang, Cui Zhu ^a  

^a Department of Haematology ^*  (China)

^b AFFILIATED PEOPLE S HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

Hypomethylation; Myelodysplastic syndrome; Preferentially expressed antigen of melanoma gene; Prognosis; Real time quantitative methylation specific PCR

Indexed keywords

PREFERENTIALLY EXPRESSED ANTIGEN OF MELANOMA PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALU SEQUENCE; CONTROLLED STUDY; CYTOGENETICS; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; IRON DEFICIENCY ANEMIA; KARYOTYPE; LETTER; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRAME GENE; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; SURVIVAL RATE; SURVIVAL TIME; TUMOR GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; DNA METHYLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROMOTER REGIONS, GENETIC; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 79958845008     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08585.x     Document Type: Letter

References (10)

1. van Baren, N., Chambost, H., Ferrant, A., Michaux, L., Ikeda, H., Millard, I., Olive, D., Boon, T. & Coulie, P.G. (1998) PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells. British Journal of Haematology, 102, 1376-1379.
2. Doolan, P., Clynes, M., Kennedy, S., Mehta, J.P., Crown, J. & O'Driscoll, L. (2008) Prevalence and prognostic and predictive relevance of PRAME in breast cancer. Breast Cancer Research and Treatment, 109, 359-365.
3. Epping, M.T., Hart, A.A., Glas, A.M., Krijgsman, O. & Bernards, R. (2008) PRAME expression and clinical outcome of breast cancer. British Journal of Cancer, 99, 398-403.
4. Oberthuer, A., Hero, B., Spitz, R., Berthold, F. & Fischer, M. (2004) The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome. Clinical Cancer Research, 10, 4307-4313.
5. Oehler, V.G., Guthrie, K.A., Cummings, C.L., Sabo, K., Wood, B.L., Gooley, T., Yang, T., Epping, M.T., Shou, Y., Pogosova-Agadjanyan, E., Ladne, P., Stirewalt, D.L., Abkowitz, J.L. & Radich, J.P. (2009) The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells. Blood, 114, 3299-3308.
6. Ortmann, C.A., Eisele, L., Nückel, H., Klein-Hitpass, L., Führer, A., Dührsen, U. & Zeschnigk, M. (2008) Aberrant hypomethylation of the cancer-testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia. Annals of Hematology, 87, 809-818.
7. Partheen, K., Levan, K., Osterberg, L., Claesson, I., Fallenius, G., Sundfeldt, K. & Horvath, G. (2008) Four potential biomarkers as prognostic factors in stage III serous ovarian adenocarcinomas. International Journal of Cancer, 123, 2130-2137.
8. Roman-Gomez, J., Jimenez-Velasco, A., Agirre, X., Castillejo, J.A., Navarro, G., Jose-Eneriz, E.S., Garate, L., Cordeu, L., Cervantes, F., Prosper, F., Heiniger, A. & Torres, A. (2007) Epigenetic regulation of PRAME gene in chronic myeloid leukemia. Leukemia Research, 31, 1521-1528.
9. Santamaría, C., Chillón, M.C., García-Sanz, R., Balanzategui, A., Sarasquete, M.E., Alcoceba, M., Ramos, F., Bernal, T., Queizán, J.A., Peñarrubia, M.J., Giraldo, P., San Miguel, J.F. & Gonzalez, M. (2008) The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia. Haematologica, 93, 1797-1805.
10. Santamaría, C.M., Chillón, M.C., García-Sanz, R., Pérez, C., Caballero, M.D., Ramos, F., de Coca, A.G., Alonso, J.M., Giraldo, P., Bernal, T., Queizán, J.A., Rodriguez, J.N., Fernández-Abellán, P., Bárez, A., Peñarrubia, M.J., Balanzategui, A., Vidriales, M.B., Sarasquete, M.E., Alcoceba, M., Díaz-Mediavilla, J., San Miguel, J.F. & Gonzalez, M. (2009) Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia. Blood, 114, 148-152.